China Biologic Products Holdings (CBPO) Debt/EBITDA US GAAP (year values)

2016 2017 2018 2019 2020   LTM ? CAGR 5 years ?
Debt/EBITDA -1.29 -1.66 -5.61 -4.78 -5.54   -5.54  
Changes by years, y/y, % -15% +29% +237% -15% +16%     +29.6%

China Biologic Products Holdings. Debt/EBITDA

China Biologic Products Holdings. Debt/EBITDA, changes, %

China Biologic Products Holdings (CBPO) Debt/EBITDA US GAAP (quarter values)

2019Q4 2020Q1 2020Q2 2020Q3 2020Q4   LTM ?
Debt/EBITDA -4.78 -4.65 -5.05 -5.49 -5.54   -5.54
Changes by years, y/y, % -15% -10% +6% +42% +16%    
Changes by quarters, q/q, % +24% -3% +9% +9% +1%    

China Biologic Products Holdings. Debt/EBITDA

China Biologic Products Holdings. Debt/EBITDA, changes, y/y, %

China Biologic Products Holdings. Debt/EBITDA, changes, q/q, %